Annual Cash & Cash Equivalents
$1.27 M
+$1.26 M+105408.33%
December 31, 2024
Summary
- As of March 10, 2025, TELO annual cash & cash equivalents is $1.27 million, with the most recent change of +$1.26 million (+105408.33%) on December 31, 2024.
- During the last 3 years, TELO annual cash & cash equivalents has risen by +$1.27 million (+100.00%).
- TELO annual cash & cash equivalents is now at all-time high.
Performance
TELO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.27 M
+$431.50 K+51.70%
December 31, 2024
Summary
- As of March 10, 2025, TELO quarterly cash and cash equivalents is $1.27 million, with the most recent change of +$431.50 thousand (+51.70%) on December 31, 2024.
- Over the past year, TELO quarterly cash and cash equivalents has stayed the same.
- TELO quarterly cash and cash equivalents is now -61.33% below its all-time high of $3.27 million, reached on March 31, 2024.
Performance
TELO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TELO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | 0.0% |
| 3 y3 years | +100.0% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
TELO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -61.3% | >+9999.0% |
| 5 y | 5-year | at high | -100.0% | -61.3% | >+9999.0% |
| alltime | all time | at high | -100.0% | -61.3% | >+9999.0% |
Telomir Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.27 M(>+9900.0%) | $1.27 M(+51.7%) |
| Sep 2024 | - | $834.60 K(-55.7%) |
| Jun 2024 | - | $1.88 M(-42.5%) |
| Mar 2024 | - | $3.27 M(>+9900.0%) |
| Dec 2023 | $1200.00 | $1200.00(-52.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $2500.00(-82.9%) |
| Jun 2023 | - | $14.60 K(+942.9%) |
| Dec 2022 | $1400.00(>+9900.0%) | - |
| Dec 2022 | - | $1400.00 |
| Dec 2021 | $0.00 | - |
FAQ
- What is Telomir Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Telomir Pharmaceuticals?
- What is Telomir Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Telomir Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Telomir Pharmaceuticals?
- What is Telomir Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Telomir Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of TELO is $1.27 M
What is the all time high annual cash & cash equivalents for Telomir Pharmaceuticals?
Telomir Pharmaceuticals all-time high annual cash & cash equivalents is $1.27 M
What is Telomir Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, TELO annual cash & cash equivalents has changed by +$1.26 M (+105408.33%)
What is Telomir Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TELO is $1.27 M
What is the all time high quarterly cash and cash equivalents for Telomir Pharmaceuticals?
Telomir Pharmaceuticals all-time high quarterly cash and cash equivalents is $3.27 M
What is Telomir Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, TELO quarterly cash and cash equivalents has changed by $0.00 (0.00%)